Rafferty Asset Management
MED icon

Rafferty Asset Management’s Medifast MED Stock Holding History

Rafferty Asset Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,716
Closed -$477K – 832
2019
Q2 		$477K Buy
+3,716
New +$516K 0.01% 701
2019
Q1 		– Sell
-3,961
Closed -$495K – 826
2018
Q4 		$495K Buy
+3,961
New +$678K 0.01% 517

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Pictet Asset Management (UK)
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Rafferty Asset Management's MED Position: Q3 2019 in Review

Rafferty Asset Management sold out of Medifast (MED) in Q3 2019, closing a stake of 3,716 shares — an estimated $477K sold.

Rafferty Asset Management first reported a position in MED in Q4 2018 and held it in 2 quarters. The position peaked at $495K in Q4 2018. 239 funds tracked by Wall St. Rank hold MED as of Q3 2019.

  • Rafferty Asset Management reported no remaining Medifast position as of Q3 2019 after selling out during the quarter.
  • Rafferty Asset Management sold 3,716 Medifast shares in Q3 2019, an estimated $477K.
  • Rafferty Asset Management first reported a position in Medifast in Q4 2018 and held it in 2 quarters.
  • Rafferty Asset Management's Medifast position peaked at $495K in Q4 2018.
  • 239 funds tracked by Wall St. Rank held Medifast as of Q3 2019.

Based on Rafferty Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.